Earlier studies demonstrated that alendronate is not effective for relieving bone density, reducing bone turnover blank and reducing the risk of men. Bisphosphonates are currently the pre-eminent ...

USES: Alendronate is used to prevent and treat fosamax tablet 70 mg types of bone loss osteoporosis in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of ...

Fosamax (alendronate) is now available in a 70-mg formulation. Are there any differences in alendronate formulation between the 10-mg tablet and the new 70-mg tablet? My question is prompted by a ...

Clinical Assistant Professor, Department of Clinical Pharmacy and Outcomes Sciences, South Carolina College of Pharmacy, Columbia, South Carolina; Clinical Pharmacy Specialist, William Jennings Bryan ...

Please provide your email address to receive an email when new articles are posted on . Among a cohort of postmenopausal women randomly assigned to romosozumab or alendronate, larger improvements in ...

A new study has shown that once-weekly oral bisphosphonate can prevent and improve bone loss in men undergoing androgen deprivation therapy (ADT) for prostate cancer. In a randomized, double-blind, ...

medwireNews: Weekly administration of oral biphosphonate alendronate could reduce loss of bone mineral density (BMD) in prostate cancer patients who start androgen-deprivation therapy (ADT), show ...

Romosozumab is a monoclonal antibody that binds to and inhibits sclerostin, increases bone formation, and decreases bone resorption. We enrolled 4093 postmenopausal women with osteoporosis and a ...

This was a 12-month, multicenter, double-blind, double-dummy, randomized, controlled trial. Eligible participants were postmenopausal women aged 45–79 years who had been treated with alendronate for ...

Author(s)Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab, alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized ...